Osteonic Co. Ltd (226400) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Osteonic Co. Ltd (226400) has a cash flow conversion efficiency ratio of 0.017x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩1.09 Billion ≈ $738.58K USD) by net assets (₩63.89 Billion ≈ $43.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see 226400 stock market capitalisation for the company's overall valuation and market capitalisation.
Osteonic Co. Ltd - Cash Flow Conversion Efficiency Trend (2015–2024)
This chart illustrates how Osteonic Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Osteonic Co. Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Osteonic Co. Ltd ranked by their cash flow conversion efficiency. Explore 226400 cash flow quality index to measure how well operating cash flow supports reported net income.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Koryo Electronics Co Ltd
TWO:8032
|
0.015x |
|
TECO Image Systems Co Ltd
TWO:5438
|
-0.017x |
|
Helbor Empreendimentos S.A
SA:HBOR3
|
0.012x |
|
VenHub Global, Inc.
NASDAQ:VHUB
|
0.150x |
|
Transpaco Ltd
JSE:TPC
|
0.106x |
|
Aptech Limited
NSE:APTECHT
|
0.008x |
|
TETHYS PETROLEUM LTD
F:TP21
|
0.112x |
|
ALT Telecom Public Company Limited
BK:ALT
|
-0.053x |
Annual Cash Flow Conversion Efficiency for Osteonic Co. Ltd (2015–2024)
The table below shows the annual cash flow conversion efficiency of Osteonic Co. Ltd from 2015 to 2024. View Osteonic Co. Ltd (226400) stock price for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩59.32 Billion ≈ $40.20 Million |
₩4.72 Billion ≈ $3.20 Million |
0.080x | -0.34% |
| 2023-12-31 | ₩51.88 Billion ≈ $35.16 Million |
₩4.14 Billion ≈ $2.81 Million |
0.080x | -26.91% |
| 2022-12-31 | ₩36.50 Billion ≈ $24.74 Million |
₩3.99 Billion ≈ $2.70 Million |
0.109x | +31.70% |
| 2021-12-31 | ₩35.53 Billion ≈ $24.08 Million |
₩2.95 Billion ≈ $2.00 Million |
0.083x | -26.84% |
| 2020-12-31 | ₩24.28 Billion ≈ $16.46 Million |
₩2.75 Billion ≈ $1.86 Million |
0.113x | +233.50% |
| 2019-12-31 | ₩28.96 Billion ≈ $19.62 Million |
₩-2.46 Billion ≈ $-1.67 Million |
-0.085x | -861.84% |
| 2018-12-31 | ₩28.50 Billion ≈ $19.31 Million |
₩317.53 Million ≈ $215.19K |
0.011x | +110.40% |
| 2017-12-31 | ₩7.43 Billion ≈ $5.03 Million |
₩-795.80 Million ≈ $-539.30K |
-0.107x | +27.68% |
| 2016-12-31 | ₩11.68 Billion ≈ $7.91 Million |
₩-1.73 Billion ≈ $-1.17 Million |
-0.148x | +26.46% |
| 2015-12-31 | ₩6.35 Billion ≈ $4.30 Million |
₩-1.28 Billion ≈ $-866.78K |
-0.201x | -- |
About Osteonic Co. Ltd
Osteonic Co., Ltd. develops, manufactures, and sells bone fixation systems. It offers CMF systems, including neuro plating systems, maxillofacial plating systems, mandible plating systems, IMF screws, power screw drivers, 90 angled screw driver, customized neuro 3D mesh, and mandible reconstruction plates under the OPTIMUS and Real FIT brand names; and biodegradable CMF plating systems under the … Read more